Published in World J Diabetes on February 15, 2014
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne) (2014) 0.87
Heart Rate and Systolic Blood Pressure Variability on Recently Diagnosed Diabetics. Arq Bras Cardiol (2015) 0.80
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy. World J Diabetes (2015) 0.80
The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. PLoS One (2016) 0.79
Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol (Lausanne) (2015) 0.79
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? World J Diabetes (2015) 0.78
Autonomic Neuropathy and Endothelial Dysfunction in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus. Medicine (Baltimore) (2016) 0.78
The spectral analysis of photoplethysmography to evaluate an independent cardiovascular risk factor. Int J Gen Med (2014) 0.78
Impact of disease control and co-existing risk factors on heart rate variability in Gujarati type 2 diabetics: An observational study. J Family Med Prim Care (2016) 0.77
Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. J Diabetes Complications (2015) 0.77
Heart-Rate Variability-More than Heart Beats? Front Public Health (2017) 0.76
Comparative study of cardiac autonomic status by heart rate variability between under-treatment normotensive and hypertensive known type 2 diabetics. Indian Heart J (2016) 0.75
Heart Rate Variability as Early Biomarker for the Evaluation of Diabetes Mellitus Progress. J Diabetes Res (2016) 0.75
Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study. BMC Cardiovasc Disord (2017) 0.75
Cardiovascular autonomic neuropathy. Proc (Bayl Univ Med Cent) (2016) 0.75
Impact of Diabetes Type 1 in Children on Autonomic Modulation at Rest and in Response to the Active Orthostatic Test. PLoS One (2016) 0.75
Explaining the increased mortality in type 1 diabetes. World J Diabetes (2015) 0.75
Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration. Cardiovasc Diabetol (2016) 0.75
Symptoms and delay times during myocardial infarction in 694 patients with and without diabetes; an explorative cross-sectional study. BMC Cardiovasc Disord (2016) 0.75
Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes. J Diabetes Res (2017) 0.75
Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function. Neurol Sci (2017) 0.75
Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients. Cardiovasc Diabetol (2017) 0.75
Novel Measure of Autonomic Remodeling Associated with Sudden Cardiac Arrest in Diabetes. Heart Rhythm (2017) 0.75
Clinical evaluation of vasomotor system functionality in type 2 diabetic Patients. Caspian J Intern Med (2017) 0.75
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation (1996) 37.54
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
Oxidative stress and diabetic complications. Circ Res (2010) 9.37
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care (2003) 4.92
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 4.58
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care (2004) 4.17
Obstructive sleep apnoea and its cardiovascular consequences. Lancet (2008) 3.73
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation (1994) 3.64
The natural history of diabetic autonomic neuropathy. Q J Med (1980) 3.36
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med (1998) 3.18
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet (1978) 3.10
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation (1998) 2.91
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology (2005) 2.74
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Diabetic autonomic neuropathy. Diabetologia (1979) 2.70
Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J (1978) 2.65
Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA (1997) 2.63
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev (2011) 2.61
Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med (1980) 2.59
Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J (2009) 2.58
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care (2010) 2.43
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.42
Software for advanced HRV analysis. Comput Methods Programs Biomed (2004) 2.38
Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med (2008) 2.38
Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J Hypertens (2007) 2.27
Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15
Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care (2008) 2.14
Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care (2007) 2.13
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation (1992) 2.09
Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation (1990) 2.03
Management of neurogenic orthostatic hypotension: an update. Lancet Neurol (2008) 2.03
Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation (1996) 2.01
Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care (2004) 1.99
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol (2006) 1.97
Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA (2011) 1.94
Diastolic heart failure. Cardiovasc Res (2000) 1.92
Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis (1999) 1.89
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study. Diabetes Care (2003) 1.79
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) (2004) 1.78
Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand (2003) 1.74
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab (2005) 1.72
Beat to beat variability in cardiovascular variables: noise or music? J Am Coll Cardiol (1989) 1.72
Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1996) 1.71
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest (1998) 1.71
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
Autonomic peripheral neuropathy. Lancet (2005) 1.63
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau. Am J Physiol Heart Circ Physiol (2001) 1.58
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med (1993) 1.54
Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care (2001) 1.53
Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study. Metabolism (2003) 1.52
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Pharmacologic modulation of autonomic tone: implications for the diabetic patient. Diabetologia (1997) 1.49
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia (1997) 1.45
The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care (2006) 1.44
Metabolic memory in diabetes--focus on insulin. Diabetes Metab Res Rev (2005) 1.43
The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med (1991) 1.42
Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease. J Neuroinflammation (2008) 1.40
EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol (2006) 1.37
Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol (1985) (1991) 1.36
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev (1994) 1.35
Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem (1996) 1.34
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications (2000) 1.33
Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med (2008) 1.33
cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem (2000) 1.33
Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev (2011) 1.32
Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology (1989) 1.30
alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation (1999) 1.30
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control. Diabetes Obes Metab (2011) 1.28
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol (2005) 1.25
Causes and consequences of increased sympathetic activity in renal disease. Hypertension (2004) 1.24
Therapeutic experience with fludrocortisone in diabetic postural hypotension. Br Med J (1976) 1.24